Indication
For adjunctive therapy in adolescents and children aged above 6 years with partial-onset seizures with or without secondary generalisation.

Medicine details

Medicine name:
eslicarbazepine acetate (Zebinix)
SMC ID:
SMC2087
Pharmaceutical company
Eisai Ltd
BNF chapter
Central nervous system
Submission type
Abbreviated submission
Status
Advice due date:
11 February 2019
SMC meeting date:
07 August 2018